Summary
This Nature Reviews Microbiology article, authored by leading microbiome researchers including Eran Elinav, examines the translation of microbiome science into personalised medicine. The review synthesises evidence on how microbiome profiling might inform individual-level clinical decision-making and discusses current applications, limitations, and future directions for microbiome-based therapeutics and diagnostics. As suggested by the journal and authorship, the paper addresses both mechanistic understanding and practical implementation challenges in moving microbiome research toward clinical utility.
Regional applicability
The review's frameworks for microbiome-informed personalised medicine are globally applicable and may inform future NHS commissioning and clinical guidelines around microbiome testing and intervention. However, implementation in the UK will require integration with existing health systems and regulatory approval pathways.
Key measures
Microbiome composition and function; clinical outcomes associated with microbiome-targeted interventions; personalization strategies in microbiome medicine
Outcomes reported
The study reviews approaches to utilising microbiome analysis for tailored clinical interventions and personalised medical management. It examines evidence and methodological frameworks for translating microbiome research into clinical practice.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.